课题基金 / 基金详情

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies
脑、乳腺和血液恶性肿瘤的演变和治疗反应
批准号:
9070719
负责人:
ERIC C. HOLLAND
金额:
$223.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-05-19 至 2020-04-30

项目摘要

项目成果

ERIC C. HOLLAND的其他基金

相似基金

相关文献

中文摘要
翻译
 描述(由申请人提供):Dana-Farber癌症研究所-物理科学-肿瘤学中心(DFCI-PSOC)将利用物理和实验科学的方法促进对癌症演变和治疗反应的理解。PSOC将组建和开发一个跨学科团队,研究和培训计划,以及围绕我们基于物理科学的框架组织的基础设施,以解决癌症研究中的一个基本问题:我们如何利用对时空方面肿瘤演变和治疗反应的定量,基于物理科学的理解来改善患者护理?我们的跨学科中心将开发和测试,单独和通过协作跨网络活动,以物理科学为基础的实验和理论概念,补充和推进我们目前对癌症生物学和肿瘤学的理解。具体而言,DFCI-PSOC旨在(i)组建和发展一个综合的跨学科研究团队,该团队将密切合作,开发和验证癌症演变和治疗反应的数学建模策略,并利用这些策略确定血液,脑和乳腺恶性肿瘤的最佳治疗干预计划,最终目标是改善患者护理。(ii)单独开发和测试 并通过协作网络活动,基于物理科学的动物模型和人类癌症样品的单细胞行为的测量策略,并利用这些测量来告知血液学、脑和乳腺恶性肿瘤中的治疗反应的数学建模策略。(iii)将物理科学的观点整合到癌症研究中,以补充和扩展我们目前对癌症在许多长度尺度和时间尺度上的理解,最终目标是改善癌症的预防,检测,诊断,预后和治疗。(iv)向PSOC网络和更广泛的科学界传播我们的发现,方法和方法,并实施教育和推广计划,与患者,学生,研究人员,倡导者和公众互动。总之,在DFCI-PSOC内开发的方法和方法将使我们能够进一步理解癌症演变和治疗反应的物理原理,最终目标是设计血液学,脑和乳腺恶性肿瘤的最佳干预策略。
英文摘要
 DESCRIPTION (provided by applicant): The Dana-Farber Cancer Institute-Physical Sciences-Oncology Center (DFCI-PSOC) will promote the understanding of cancer evolution and treatment responses utilizing approaches from the physical and experimental sciences. The PSOC will assemble and develop a trans- disciplinary team, research and training programs, and infrastructure organized around our physical sciences-based framework to address a fundamental question in cancer research: how can we utilize a quantitative, physical sciences-based understanding of the spatio-temporal aspects tumor evolution and treatment response to improve patient care? Our trans-disciplinary center will develop and test, individually and through collaborative trans-network activities, physical sciences-based experimental and theoretical concepts that complement and advance our current understanding of cancer biology and oncology. Specifically, the DFCI-PSOC aims to (i) Assemble and develop an integrated trans-disciplinary research team that will work closely together to develop and validate mathematical modeling strategies of cancer evolution and treatment response, and utilize these strategies to identify best therapeutic intervention schedules for hematologic, brain and breast malignancies, with the ultimate goal of improving patient care. (ii) Develop and test, individually and through collaborative network activities, strategies for physical sciences-based measurements of single cell behavior of both animal model and human cancer samples, and utilize these measurements to inform mathematical modeling strategies of treatment response in hematologic, brain and breast malignancies. (iii) Integrate physical sciences perspectives into cancer research to complement and expand on our current understanding of cancer across many length-scales and time-scales, with the ultimate goal of improving cancer prevention, detection, diagnosis, prognosis, and therapy. (iv) Disseminate our findings, approaches and methodologies to the PSOC network and the wider scientific community as well as implement education and outreach programs to interact with patients, students, researchers, advocates, and the general public. Together, the approaches and methodologies developed within the DFCI-PSOC will enable us to further our understanding of the physical principles underlying cancer evolution and treatment response with the ultimate goal of designing optimum intervention strategies for hematologic, brain and breast malignancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer
  • 批准号:
    10689283
  • 项目类别:
  • 资助金额:
    $83.99万
  • 财政年份:
    2021
  • 负责人:
    ERIC C. HOLLAND
  • 依托单位:
The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer
The role and mechanism of alternative RNA splice variants and gene fusions as drivers of cancer
  • 批准号:
    10644172
  • 项目类别:
  • 资助金额:
    $12.83万
  • 财政年份:
    2021
  • 负责人:
    ERIC C. HOLLAND
  • 依托单位:
Biology and therapy of C11orf95-RELA fusion-driven ependymoma
海外基金